ICARS at the UNGA2024: Driving Sustainable Change through Country-Owned and Context-Specific Solutions

ICARS will participate in the UN General Assembly’s High-Level Meeting on Antimicrobial Resistance (AMR) in New York in September 2024, a crucial event where global leaders will address the cross-border threat of AMR to global health, food security, economic development, and the 2030 Sustainable Development Goals. As an organisation working with Low- and Middle-Income Countries (LMICs) to create context-specific and country-owned solutions, ICARS is eager to share our insights and support global efforts against AMR. We remain committed to advancing the One Health approach and fostering partnerships for sustainable change.

This webpage is designed to provide updates on the UN General Assembly, including ICARS’ events, participation, and related developments.

Our events and participation

ICARS is honoured to attend the UN General Assembly High-Level Meeting and co-host several side events with a range of diverse partners. Below, you’ll find a summary of each event and the key messages associated with them.

Ensuring sustainable access to effective antibiotics: The path from UNGA to Impact

September 22nd

Key voices from across the globe shed light on the AMR crisis, propose evidence-based solutions, and unite in a call to action to ensure the sustainability of antibiotics and our collective health. ICARS’ Ghada Zoubiane will speak on a panel about public understanding of AMR.

Co-hosts: One Health Trust, Africa Centres for Disease Control and Prevention, the United States Centers for Disease Control and Prevention, the International Federation of Pharmaceutical Manufacturers & Associations, Global AMR R&D Hub, FIND, the AMR Action Fund, the Infectious Disease Society of America, and the Bill & Melinda Gates Foundation

From Policy to Action: Successful implementation of multisectoral AMR programs in LMICs

September 24th

By bringing together country representatives, policymakers, AMR specific donors and regional and international organisations, this side-event will serve as a discussion and exchange of best practices, as well as an opportunity to present examples of successful AMR interventions across the One Health Spectrum. ICARS’ Sujith J. Chandy will present, alongside ICARS partners from Brazil, Cambodia, Colombia, Kosovo and Zambia. Sabiha Essack will end the session with reflections on the UN Declaration on AMR.

Co-hosts: World Medical Association

Bringing the voices and perspectives of Low- and Middle-Income Countries into the Global Policy Dialogue

September 25th

A high-level dialogue to discuss the perspectives of Low- and Middle-Income Countries (LMICs) and vulnerable communities most impacted by antimicrobial resistance (AMR). The facilitated discussion will focus on the experiences, challenges, and successes in implementing multisectoral National Action Plans (NAPs) through a One Health approach, with a focus on equitable access to sustainable solutions. Sujith J. Chandy will present, alongside ICARS partners from LMICs.

Co-hosts: The Quadripartite Joint Secretariat on AMR

UN General Assembly High-Level Meeting on antimicrobial resistance

September 26th

The theme of the high-level meeting is ‘Investing in the present and securing our future together: Accelerating multi-sectoral global, regional and national actions to address Antimicrobial Resistance’. This headline event is a critical opportunity for political leaders to approve a new declaration which contains concrete targets and practical steps for addressing the urgent issue of antimicrobial resistance around the world.

Our Vision

Prior to the UN General Assembly, ICARS released a set of recommendations to member states and the global AMR community, which we are committed to upholding through our work.  Below you can read about how these recommendations are woven through ICARS’ model of working, with specific examples from our activities around the world.

Promote science-policy-implementation dialogue and interface  

Although extensive research has revealed successful solutions for mitigating AMR, there is a critical gap in translating these evidence-based solutions into actions. Many countries have developed AMR NAPs, but only a third have been costed with monitoring and evaluation plans in place. In resource limited settings, the challenge remains how best to prioritise and implement solutions to mitigate AMR. ICARS specifically addresses the challenge of NAP implementation in LMICs by practicing a bottom-up (investigator driven), top-down (policy-driven) approach to bridge the science into policy gap.

In Benin, the NAP highlighted the need for more attention to be paid to AMR in the poultry sector. To address this Professor Victorien Dougnon is coordinating an ICARS project to reduce the import of antimicrobial resistance into Benin through day-old chicks and hatching eggs. “We work closely with ministry people and have full support from their side, so when we get interesting results, they are ready to take action.”

Support setting up a sustainable ecosystem of evidence and innovation generation

To achieve sustainable change with maximum impact, ICARS’ projects aim to strengthen relevant in-country research capabilities to support the uptake of context-specific solutions into policy. Because AMR is a One Health problem, we take multidisciplinary approaches and aim to mobilise a range of sectors to achieve better outcomes.

Daniel Joshua Msesa is a Public Health Specialist based at the Zanzibar Health Research Institute working on an ICARS project that aims to improve diagnostics uptake and enhance antimicrobial stewardship activities. In this video he discusses how “working with a multidisciplinary team has been enlightening and rewarding.”

Advocate for context-specific and country-owned solutions

ICARS’ activities are designed to empower country leadership by engaging with and listening to local knowledge and experience. Our co-development process ensures AMR mitigation priorities are self-identified by country teams to address local and national needs, build on existing efforts, and feed into or build on existing National Action Plans.

Ntombi Mudenda from the University of Zambia, School of Veterinary Medicine is engaged with an innovative ICARS project that works with small-scale farmers to reduce both antimicrobial use in broiler production and residue presence in broiler meat. In this video she stresses the importance of building local-ownership: “Make sure that before you actually start the study, you get people on board who are going to help you actually get to the people that you need to get to and get some buy-in to the project.”

Approach AMR as a horizontal challenge  

Antimicrobial resistance is a global challenge that transcends sectors and demands integrated and synergistic action. AMR mitigation should be seen as an integrated part of many other aspects of One Health system strengthening initiatives, such as vaccination, biosecurity, infection prevention and control, WASH, pandemic preparedness, sustainable food systems, waste management, access to healthcare and diagnostics. ICARS believes working horizontally could generate substantial co-benefits and bridge investment gaps.

ICARS has an ongoing partnership with the International Vaccines Institute (IVI) to align vaccine and AMR strategies within the context of Low- and Middle-Income Countries, with a recent RFP launched for regional work in South and South-East Asia. Furthermore, in collaboration with the International Development Research Centre (IDRC), ICARS funded a project which sought to identify practical pathways for integrating gender and equity considerations into antimicrobial resistance research. The ‘practical pathways’ resources provide researchers with hands-on support for incorporating gender and equity considerations into their studies.

Practical Pathways Resource

 

Strengthen global governance and leadership

A declaration is only valuable when commitments are translated into action. ICARS is proud to be a member of the AMR Multi-Stakeholder Partnership Platform , established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO and WOAH), to catalyse a global movement for action against AMR. By fostering cooperation between a diverse range of stakeholders the platform aims to leverage efforts across all levels of the One Health spectrum. ICARS is currently actively engaged across a range of MSPP Action Groups.

Learn more

15 November 2023, Rome, Italy – Antimicrobial Resistance (AMR) Multi-Stakeholder Partnership Platform Inaugural Plenary Assembly. (Red Room) FAO Headquarters.

Transform AMR funding 

The ICARS model, which fosters local-ownership by working top- down and bottom-up with local partners, is also intended to generate more efficient and sustainable funding streams to our projects. With a strategic focus on cost-effectiveness and partnership, and a core pillar of our work focused on capacity building, we hope to increase opportunities for country-led project expansion, scale-up and complimentary initiatives.

In May 2024 we co-hosted a side-event during the World Health Assembly which focused on ways to optimise current and new funding mechanisms for AMR mitigation. The follow-up brief provides considerations for thinking beyond the traditional Overseas Development Assistance model, and instead prioritising mobilisation of domestic funding, identifying different investment models and sources at regional and national levels.

Read the report

 

Live from UNGA!

Get involved

Sign up for the ICARS newsletter

ICARS mails out a newsletter each quarter with an update on our recent activities, resources and opportunities. Subscribe to stay up to date on our work and be notified of upcoming opportunities.

Subscribe

Follow us on Social Media

ICARS has an active presence on LinkedIn and X. Follow us for recommended reading, news, analysis and announcements.

X

LinkedIn